Profile of:

Helena Forsblad-d'Elia

Full name: Helena Forsblad-d'Elia

Current country: Sweden

Membership level: Full

Type of membership: Member

Number of publications: 37

Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT. (2021)

Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? (2021)

Anti-CD74 IgA autoantibodies in radiographic axial spondyloarthritis: a longitudinal Swedish study (2021)

Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study (2021)

Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis (2021)

Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing spondylitis (2021)

Biomechanical Properties of Common Carotid Arteries Assessed by Circumferential 2D Strain and β Stiffness Index in Patients With Ankylosing Spondylitis (2021)

Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci (2020)

Cardiac conduction disturbances in patients with ankylosing spondylitis: results from a 5-year follow-up cohort study (2019)

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin (2019)

Comparison of agreement between internet-based registration of patient-reported outcomes and clinic-based paper forms within the Swedish Rheumatology Quality Register (2019)

Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study (2019)

Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis (2019)

Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex (2018)

A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis (2018)

Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden (2018)

Patterns of comorbidity and disease characteristics among patients with ankylosing spondylitis-a cross-sectional study (2018)

Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study (2017)

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study (2017)

Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register (2017)

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis (2017)

Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study (2016)

The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study (2016)

Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers (2016)

Mortality in ankylosing spondylitis: results from a nationwide population-based study (2016)

Aortic Regurgitation Is Common in Ankylosing Spondylitis: Time for Routine Echocardiography Evaluation? (2015)

The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study (2015)

Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register (2015)

The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study (2015)

Prevalence of diastolic dysfunction in patients with ankylosing spondylitis: a cross-sectional study (2015)

Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis (2014)

Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes (2013)

Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study (2013)

Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis (2013)

Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton (2012)

Osteoporosis in ankylosing spondylitis – prevalence, risk factors and methods of assessment (2012)

Calprotectin in ankylosing spondylitis–frequently elevated in feces, but normal in serum (2012)